Literature DB >> 12480324

Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres.

B Kim1, T Bowersock, P Griebel, A Kidane, L A Babiuk, M Sanchez, S Attah-Poku, R S Kaushik, G K Mutwiri.   

Abstract

Availability of effective oral vaccine delivery vehicles should contribute to the success of oral immunization in domestic animals. To achieve this goal, we evaluated alginate microspheres for their capacity to induce mucosal immune responses following oral and enteric immunizations. Mice were immunized with either live porcine rotavirus (PRV) or its recombinant VP6 protein, encapsulated in alginate microspheres or unencapsulated. VP6-specific IgG (but no IgA) antibodies were detected in the sera of mice after a single intraperitoneal (i.p.) immunization with either VP6 in Incomplete Freund's adjuvant (VP6-IFA), VP6 in alginate microspheres (VP6-MS) or with live PRV in incomplete Freund's adjuvant (PRV-IFA). In contrast, VP6-specific IgA (but no IgG) was detected in culture supernatants of mesenteric lymph nodes from mice immunized i.p. with either VP6-IFA or with PRV-IFA. Oral immunization with VP6-MS induced the highest level of VP6-specific fecal IgA antibody, similar to responses induced by oral immunization with live PRV. Furthermore, the VP6-specific fecal IgA could be boosted by a secondary i.p. immunization with VP6. Further experiments were performed in a sheep intestinal 'loop' model to evaluate uptake of microspheres by Peyer's patches. Microspheres containing colloidal carbon were specifically bound and transported by follicle-associated epithelium of Peyer's patches. Additionally, mucosal immune responses were detected following enteric immunization with porcine serum albumin (PSA) encapsulated in alginate microspheres. Our results confirm that alginate microspheres are an effective oral delivery vehicle for protein antigens and intestinal IgA antibody responses are induced by antigens encapsulated in alginate microspheres without any additional mucosal adjuvant. These investigations confirm that alginate microspheres have the potential as an effective delivery vehicle for oral immunization of ruminants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480324     DOI: 10.1016/s0168-3659(02)00280-8

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

Review 1.  Applications of alginate microspheres in therapeutics delivery and cell culture: Past, present and future.

Authors:  Dinesh Dhamecha; Rachel Movsas; Ugene Sano; Jyothi U Menon
Journal:  Int J Pharm       Date:  2019-08-14       Impact factor: 5.875

Review 2.  Mucosal vaccines: recent progress in understanding the natural barriers.

Authors:  Olga Borges; Filipa Lebre; Dulce Bento; Gerrit Borchard; Hans E Junginger
Journal:  Pharm Res       Date:  2009-12-01       Impact factor: 4.200

Review 3.  Therapeutic applications of hydrogels in oral drug delivery.

Authors:  Lindsey A Sharpe; Adam M Daily; Sarena D Horava; Nicholas A Peppas
Journal:  Expert Opin Drug Deliv       Date:  2014-06       Impact factor: 6.648

4.  Assessment of the immunogenicity of rabies vaccine preserved by vaporization and delivered to the duodenal mucosa of gray foxes (Urocyon cinereoargenteus).

Authors:  Todd G Smith; Xianfu Wu; James A Ellison; Ashutosh Wadhwa; Richard Franka; Gregory L Langham; Brianna L Skinner; Cathleen A Hanlon; Victor L Bronshtein
Journal:  Am J Vet Res       Date:  2017-06       Impact factor: 1.156

5.  Covalent layer-by-layer assembly of hyperbranched polymers on alginate microcapsulesto impart stability and permselectivity.

Authors:  Km Gattás-Asfura; M Valdes; E Celik; Cl Stabler
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

Review 6.  Developments in Vaccine Adjuvants.

Authors:  Farrhana Ziana Firdaus; Mariusz Skwarczynski; Istvan Toth
Journal:  Methods Mol Biol       Date:  2022

7.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

Review 8.  pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.

Authors:  Lin Liu; WenDong Yao; YueFeng Rao; XiaoYang Lu; JianQing Gao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Preparation of alginate coated chitosan microparticles for vaccine delivery.

Authors:  Xingyi Li; XiangYe Kong; Shuai Shi; XiuLing Zheng; Gang Guo; YuQuan Wei; ZhiYong Qian
Journal:  BMC Biotechnol       Date:  2008-11-19       Impact factor: 2.563

10.  Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs.

Authors:  Basavaraj Binjawadagi; Varun Dwivedi; Cordelia Manickam; Kang Ouyang; Yun Wu; Ly James Lee; Jordi B Torrelles; Gourapura J Renukaradhya
Journal:  Int J Nanomedicine       Date:  2014-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.